Our study detected anti-DFS70 antibodies in a variety of autoimmune diseases, including JIA (22.4%) and cSLE (23.5%), but the frequency was lower than in ANA-positive patients without autoimmune or rheumatic disease (46.6%). Here, BTG3 is linked to autoimmune disease.